Shen Y, Zhao H, Wang X, Wu S, Wang Y, Wang C
Front Immunol. 2024; 15:1406213.
PMID: 39524445
PMC: 11543477.
DOI: 10.3389/fimmu.2024.1406213.
Hu X, Ding S, Lu G, Lin Z, Liao L, Xiao W
Cancer Immunol Immunother. 2023; 72(12):4123-4144.
PMID: 37853273
PMC: 10992383.
DOI: 10.1007/s00262-023-03547-8.
Zhu K, Wu M, Zhang D, Guo H, Zhang N, Guo L
Int J Mol Sci. 2020; 21(16).
PMID: 32824641
PMC: 7460618.
DOI: 10.3390/ijms21165916.
Mamipour M, Yousefi M, Dehnad A, Faridvand Y, Zarezadeh R, Khaksar M
J Cardiovasc Thorac Res. 2020; 12(1):35-42.
PMID: 32211136
PMC: 7080329.
DOI: 10.34172/jcvtr.2020.06.
Kingsley M, Vishnu Bhat B, Badhe B, Dhas B, Parija S
Sci Rep. 2020; 10(1):2947.
PMID: 32076015
PMC: 7031385.
DOI: 10.1038/s41598-020-59716-7.
A TLR4-derived non-cytotoxic, self-assembling peptide functions as a vaccine adjuvant in mice.
Tandon A, Pathak M, Harioudh M, Ahmad S, Sayeed M, Afshan T
J Biol Chem. 2018; 293(51):19874-19885.
PMID: 30385503
PMC: 6314143.
DOI: 10.1074/jbc.RA118.002768.
Porphyromonas gingivalis gingipains selectively reduce CD14 expression, leading to macrophage hyporesponsiveness to bacterial infection.
Wilensky A, Tzach-Nahman R, Potempa J, Shapira L, Nussbaum G
J Innate Immun. 2014; 7(2):127-135.
PMID: 25228314
PMC: 4348206.
DOI: 10.1159/000365970.
Expression of toll-like receptors on human rectal adenocarcinoma cells.
Tchorzewski M, Lewkowicz P, Dziki A, Tchorzewski H
Arch Immunol Ther Exp (Warsz). 2014; 62(3):247-51.
PMID: 24390484
PMC: 4024133.
DOI: 10.1007/s00005-013-0260-z.
Toll-Like Receptors (TLRs): The Role in Tumor Progression.
Shcheblyakov D, Logunov D, Tukhvatulin A, Shmarov M, Naroditsky B, Gintsburg A
Acta Naturae. 2012; 2(3):21-9.
PMID: 22649649
PMC: 3347570.
Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants.
Shanmugam A, Rajoria S, George A, Mittelman A, Suriano R, Tiwari R
PLoS One. 2012; 7(2):e30839.
PMID: 22363498
PMC: 3282694.
DOI: 10.1371/journal.pone.0030839.
Toll-like receptors and myocardial ischemia/reperfusion, inflammation, and injury.
Kaczorowski D, Nakao A, McCurry K, Billiar T
Curr Cardiol Rev. 2010; 5(3):196-202.
PMID: 20676278
PMC: 2822142.
DOI: 10.2174/157340309788970405.
A clear and present danger: endogenous ligands of Toll-like receptors.
Sloane J, Blitz D, Margolin Z, Vartanian T
Neuromolecular Med. 2009; 12(2):149-63.
PMID: 19830599
PMC: 2908951.
DOI: 10.1007/s12017-009-8094-x.
Drosophila neurotrophins reveal a common mechanism for nervous system formation.
Zhu B, Pennack J, McQuilton P, Forero M, Mizuguchi K, Sutcliffe B
PLoS Biol. 2008; 6(11):e284.
PMID: 19018662
PMC: 2586362.
DOI: 10.1371/journal.pbio.0060284.
Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases.
Leon C, Tory R, Jia J, Sivak O, Wasan K
Pharm Res. 2008; 25(8):1751-61.
PMID: 18493843
PMC: 2469272.
DOI: 10.1007/s11095-008-9571-x.
Nickel alterations of TLR2-dependent chemokine profiles in lung fibroblasts are mediated by COX-2.
Brant K, Fabisiak J
Am J Respir Cell Mol Biol. 2007; 38(5):591-9.
PMID: 18096868
PMC: 2335339.
DOI: 10.1165/rcmb.2007-0314OC.
Evolutionary analysis for functional divergence of the toll-like receptor gene family and altered functional constraints.
Zhou H, Gu J, Lamont S, Gu X
J Mol Evol. 2007; 65(2):119-23.
PMID: 17762905
DOI: 10.1007/s00239-005-0008-4.
Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis.
Wagenlehner F, Weidner W, Naber K
Clin Pharmacokinet. 2007; 46(4):291-305.
PMID: 17375981
DOI: 10.2165/00003088-200746040-00003.
Anti-inflammatory effect of bioflora probiotic administered orally or subcutaneously with live or dead bacteria.
Laudanno O, Vasconcelos L, Catalana J, Cesolari J
Dig Dis Sci. 2006; 51(12):2180-3.
PMID: 17080255
DOI: 10.1007/s10620-006-9175-4.
Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter.
Ramanathan M, Pinhal-Enfield G, Hao I, Leibovich S
Mol Biol Cell. 2006; 18(1):14-23.
PMID: 17065555
PMC: 1751314.
DOI: 10.1091/mbc.e06-07-0596.
The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.
Lievin-Le Moal V, Servin A
Clin Microbiol Rev. 2006; 19(2):315-37.
PMID: 16614252
PMC: 1471992.
DOI: 10.1128/CMR.19.2.315-337.2006.